Hi̇lmi̇ Orhan

1.9k total citations
48 papers, 1.5k citations indexed

About

Hi̇lmi̇ Orhan is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Hi̇lmi̇ Orhan has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Pharmacology and 6 papers in Organic Chemistry. Recurrent topics in Hi̇lmi̇ Orhan's work include Drug-Induced Hepatotoxicity and Protection (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Free Radicals and Antioxidants (5 papers). Hi̇lmi̇ Orhan is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Free Radicals and Antioxidants (5 papers). Hi̇lmi̇ Orhan collaborates with scholars based in Türkiye, Netherlands and United States. Hi̇lmi̇ Orhan's co-authors include Gönül Şahin, Nico Vermeulen, John H.N. Meerman, Ahmet Aydın, Aşkın Işimer, Ahmet Sayal, Metin Özata, Hande Gürer-Orhan, Aykan Yücel and Lütfü Önderoğlu and has published in prestigious journals such as Biochemical Journal, Free Radical Biology and Medicine and Anesthesiology.

In The Last Decade

Hi̇lmi̇ Orhan

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hi̇lmi̇ Orhan Türkiye 19 399 181 168 164 131 48 1.5k
Murat Yağmurca Türkiye 22 276 0.7× 207 1.1× 88 0.5× 158 1.0× 77 0.6× 31 1.6k
Pabitra Bikash Pal India 15 844 2.1× 191 1.1× 149 0.9× 161 1.0× 112 0.9× 17 2.1k
Eduardo Molina‐Jijón Mexico 24 809 2.0× 229 1.3× 215 1.3× 176 1.1× 162 1.2× 35 2.1k
Güngör Kanbak Türkiye 22 549 1.4× 251 1.4× 83 0.5× 285 1.7× 73 0.6× 87 1.7k
Atilla İlhan Türkiye 21 303 0.8× 248 1.4× 92 0.5× 160 1.0× 56 0.4× 45 1.7k
Dragan Djurić Serbia 20 356 0.9× 326 1.8× 84 0.5× 231 1.4× 138 1.1× 178 2.0k
Wylly Ramsés García‐Niño Mexico 17 456 1.1× 154 0.9× 216 1.3× 226 1.4× 93 0.7× 29 1.4k
Yingjun Zhou China 27 529 1.3× 277 1.5× 153 0.9× 185 1.1× 106 0.8× 84 1.8k
Aşkın Işimer Türkiye 22 311 0.8× 336 1.9× 202 1.2× 295 1.8× 100 0.8× 59 1.7k
Krishnendu Sinha India 17 903 2.3× 200 1.1× 178 1.1× 180 1.1× 105 0.8× 28 2.4k

Countries citing papers authored by Hi̇lmi̇ Orhan

Since Specialization
Citations

This map shows the geographic impact of Hi̇lmi̇ Orhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hi̇lmi̇ Orhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hi̇lmi̇ Orhan more than expected).

Fields of papers citing papers by Hi̇lmi̇ Orhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hi̇lmi̇ Orhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hi̇lmi̇ Orhan. The network helps show where Hi̇lmi̇ Orhan may publish in the future.

Co-authorship network of co-authors of Hi̇lmi̇ Orhan

This figure shows the co-authorship network connecting the top 25 collaborators of Hi̇lmi̇ Orhan. A scholar is included among the top collaborators of Hi̇lmi̇ Orhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hi̇lmi̇ Orhan. Hi̇lmi̇ Orhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orhan, Hi̇lmi̇, et al.. (2025). Silybin, silychristin and silydianin are potential novel plant-based Pannexin1 channel inhibitors. International Immunopharmacology. 164. 115316–115316.
2.
Yenıay, Levent, Yiğit Özer Tiftikçioğlu, Osman Zekioğlu, et al.. (2024). Blood and tissue levels of persistent organic pollutants and genetic susceptibility in patients with breast cancer. Environmental Toxicology and Pharmacology. 108. 104433–104433. 3 indexed citations
3.
Orhan, Hi̇lmi̇, et al.. (2024). The cytotoxic, genotoxic and mitotoxic effects of Atractylis gummifera extract in vitro. African Health Sciences. 24(1). 295–306. 3 indexed citations
4.
Orhan, Hi̇lmi̇, et al.. (2021). Mitochondrial Biotransformation of Drugs and other Xenobiotics. Current Drug Metabolism. 22(8). 657–669. 6 indexed citations
5.
Akakpo, Jephte Y., Anup Ramachandran, Hi̇lmi̇ Orhan, et al.. (2020). 4-methylpyrazole protects against acetaminophen-induced acute kidney injury. Toxicology and Applied Pharmacology. 409. 115317–115317. 44 indexed citations
6.
Orhan, Hi̇lmi̇, et al.. (2020). Bioactivation of clozapine by mitochondria of the murine heart: Possible cause of cardiotoxicity. Toxicology. 447. 152628–152628. 27 indexed citations
7.
Orhan, Hi̇lmi̇, et al.. (2016). Metal pollution in biotic and abiotic samples of the Büyük Menderes River, Turkey. Environmental Science and Pollution Research. 24(5). 4274–4283. 19 indexed citations
8.
Özaydın, Okan, et al.. (2015). Periodic monitoring of persistent organic pollutants and molecular damage in Cyprinus carpio from Büyük Menderes River. Environmental Science and Pollution Research. 24(5). 4241–4251. 9 indexed citations
9.
Orhan, Hi̇lmi̇, et al.. (2014). Environmental and biological monitoring of persistent organic pollutants in waterbirds by non-invasive versus invasive sampling. Toxicology Letters. 230(2). 208–217. 30 indexed citations
10.
Orhan, Hi̇lmi̇, Altan Şahin, Gönül Şahin, Ülkü Aypar, & Nico Vermeulen. (2012). Urinary lipid and protein oxidation products upon halothane, isoflurane, or sevoflurane anesthesia in humans: potential biomarkers for a subclinical nephrotoxicity. Biomarkers. 18(1). 73–81. 9 indexed citations
11.
Gürer-Orhan, Hande, et al.. (2008). Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats. Experimental and Toxicologic Pathology. 61(1). 23–32. 77 indexed citations
12.
Gürer-Orhan, Hande, et al.. (2006). Synthesis and evaluation ofin vitroantioxidant capacities of some benzimidazole derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(2). 241–247. 25 indexed citations
13.
Gürer-Orhan, Hande, Hi̇lmi̇ Orhan, Nico Vermeulen, & John H.N. Meerman. (2006). Screening the Oxidative Potential of Several Mono- and Di-Halogenated Biphenyls and Biphenyl Ethers in Rat Hepatocytes. Combinatorial Chemistry & High Throughput Screening. 9(6). 449–454. 5 indexed citations
14.
Orhan, Hi̇lmi̇, Chris T. Evelo, & Gönül Şahin. (2005). Erythrocyte antioxidant defense response against cigarette smoking in humans—the glutathione S‐transferase vulnerability. Journal of Biochemical and Molecular Toxicology. 19(4). 226–233. 39 indexed citations
15.
Özışık, Pınar, Servet İnci, Figen Söylemezoğlu, Hi̇lmi̇ Orhan, & Tunçalp Özgen. (2005). Comparative dural closure techniques: a safety study in rats. Surgical Neurology. 65(1). 42–47. 28 indexed citations
17.
Orhan, Hi̇lmi̇, Lütfü Önderoğlu, Aykan Yücel, & Gönül Şahin. (2003). Circulating biomarkers of oxidative stress in complicated pregnancies. Archives of Gynecology and Obstetrics. 267(4). 189–195. 103 indexed citations
19.
Orhan, Hi̇lmi̇ & Gönül Şahin. (2001). In vitro effects of NSAIDS and paracetamolon oxidative stress-related parameters of human erythrocytes. Experimental and Toxicologic Pathology. 53(2-3). 133–140. 71 indexed citations
20.
Orhan, Hi̇lmi̇, et al.. (1999). The in vitro effects of new non-steroidal antiinflammatory compounds on antioxidant system of human erythrocytes. Experimental and Toxicologic Pathology. 51(4-5). 397–402. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026